Capital International Investors Applied Molecular Transport Inc. Transaction History

Capital International Investors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.63 - $13.88 $4.36 Million - $10.8 Million	-775,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $4.77 Million - $7.72 Million	120,000 Added 18.31%	775,300 $35.5 Million
Q2 2020 Aug 14, 2020	BUY	$17.98 - $28.0 $11.8 Million - $18.3 Million	655,300 New	655,300 $16.5 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.